Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 06-12-2017, 06:44 PM #1
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default DDC inhibitor v COMT inhibitor

As I understand it, there are two distinct mechanisms which have been used to reduce the peripheral metabolism of levodopa:

- DDC inhibitor (e.g carbidopa). Carbidopa [1] "inhibits aromatic-L-amino-acid decarboxylase (DOPA decarboxylase or DDC), ... an enzyme important in the ... biosynthesis of L-DOPA to dopamine (DA). DDC exists both outside of (body periphery) and within the confines of the blood brain barrier."

- COMT inhibitor (e.g. entacapone). Entacapone [2] "is a selective and reversible inhibitor of the enzyme catechol-O-methyltransferase (COMT)... When taken together with levodopa (L-DOPA) and carbidopa, entacapone stops catechol-O-methyltransferase from breaking down and metabolizing levodopa, resulting in an overall increase of levodopa remaining in the brain and body."

So, there's Sinemet (= levodopa + carbidopa) and Stalevo (= levodopa + carbidopa + entacapone). But, I've never seen levodopa + entacapone (i.e. without carbidopa). Why is this?

References:

[1] Carbidopa - Wikipedia

[2] Entacapone - Wikipedia

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg

Last edited by johnt; 06-12-2017 at 06:50 PM. Reason: typo
johnt is offline   Reply With QuoteReply With Quote

advertisement
Old 06-12-2017, 08:35 PM #2
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default My understanding

My understanding regarding DDC inhibitors is as follows:
- if you don't add a DDC inhibitor (i.e. carbidopa/benserazide), you need to use a much larger dose of levodopa, in order for sufficient levodopa to make it into the brain;
- such large doses of levodopa cause unwanted side effects (e.g. nausea).

My understanding regarding COMT inhibitors is that their main function (in PD treatment) is to (try to) stop COMT from breaking down dopamine in the brain.
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
johnt (06-13-2017)
Old 06-13-2017, 02:37 AM #3
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

Jeffreyn,

Thanks for your prompt reply.

I agree when you write:
"- if you don't add a DDC inhibitor (i.e. carbidopa/benserazide), you need to use a much larger dose of levodopa, in order for sufficient levodopa to make it into the brain;
- such large doses of levodopa cause unwanted side effects (e.g. nausea)."

You write:
"My understanding regarding COMT inhibitors is that their main function (in PD treatment) is to (try to) stop COMT from breaking down dopamine in the brain."

I'm not familiar with this process. However, what you describe is the role played by MAO-B inhibitors (e.g. rasagiline) [1].
"Selective MAOB inhibitors ... preferentially [inhibit] MAOB, which mostly metabolizes DA. If MAOB is inhibited, then more DA is available for proper neuronal function, especially in Parkinson's Disease.

In a recent doctorial thesis [2] I've found a reference to the effect of levodopa plus entacapone without carbidopa:
"That the Cmax and AUC of levodopa in both CSF and blood increased significantly when additional entacapone was given alone and in combination with carbidopa. The increase was more evident when entacapone was combined with carbidopa."

Reference:

[1] Monoamine oxidase B - Wikipedia

[2] "Levodopa pharmacokinetics-from stomach to brain"
Maria Nord,
Dissertation, Linkoping University, 2017
https://liu.diva-portal.org/smash/ge...FULLTEXT01.pdf

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (06-13-2017)
Old 06-13-2017, 08:37 AM #4
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

John, it's not just levodopa that the COMT enzyme acts on, it's all the catecholamines as well.

From Wikipedia (see link):
"Catechol-O-methyltransferase (COMT) is one of several enzymes that degrade catecholamines (such as dopamine, epinephrine, and norepinephrine), catecholestrogens, and various drugs and substances having a catechol structure."

Catechol-O-methyl transferase - Wikipedia

In regards to your main point, if you had a drug which contained just levodopa and entacapone, you wouldn't be able to stop the DDC enzyme from converting a lot of the levodopa into dopamine, before the levodopa made it into the brain. The dopamine produced in this way would be of no benefit to the PwP, since dopamine cannot pass through the blood-brain barrier.
jeffreyn is offline   Reply With QuoteReply With Quote
Old 06-13-2017, 09:21 AM #5
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

i don't think carbidopa and entacapone pass the BBB. if carbidopa entered the brain very little l-dopa would be converted to dopamine in the brain. this feature made carbidopa so attractive and reduced the l-dopa dosage from over 10grams and impractical to use to treat pd for the masses to what it is today.


entacapone also doesn't cross the BBB which makes it less potent than Tolcapone (tasmar) which i think is no longer used in the U.S. over liver toxicity risks and the need to monitor that.

Medscape: Medscape Access
Entacapone is highly protein bound, approximately 98%, with a limited body distribution.[42,44] It has poor brain penetration and predominately peripheral effects, although it may exhibit central effects if given in high doses.[
soccertese is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (06-13-2017), Tupelo3 (06-13-2017)
Old 06-13-2017, 10:54 AM #6
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

ST is correct, entacapone has limited ability to pass the BBB. Tolcapone had significantly better absorption in both the body and brain.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (06-13-2017)
Old 06-13-2017, 08:19 PM #7
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default My new understanding

Okay, it seems clear now that my understanding of the role played by COMT inhibitors was faulty.

My new understanding is as follows:
The main purpose of COMT inhibitors (in PD treatment) is to (try to) stop the COMT enzyme from breaking down levodopa (mainly outside of the brain).
jeffreyn is offline   Reply With QuoteReply With Quote
Old 06-13-2017, 10:08 PM #8
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

Johnt, sorry for derailing your thread with my misunderstanding regarding the role of COMT inhibitors. Soccertese and Tupelo3, thanks for helping to clear up that misunderstanding.

John's initial question still stands: why isn't there a drug which just contains levodopa and entacapone?

As I said earlier, my understanding is as follows:
"If you had a drug which contained just levodopa and entacapone, you wouldn't be able to stop the DDC enzyme from converting a lot of the levodopa into dopamine, before the levodopa made it into the brain." Which means you would need to use a lot more levodopa, which means you would get more severe side effects (e.g. nausea).

Is my understanding correct? Are there any other reasons?
jeffreyn is offline   Reply With QuoteReply With Quote
Old 06-21-2017, 10:25 AM #9
TexasTom TexasTom is offline
Member
 
Join Date: Jun 2015
Location: Austin, Texas
Posts: 112
8 yr Member
TexasTom TexasTom is offline
Member
 
Join Date: Jun 2015
Location: Austin, Texas
Posts: 112
8 yr Member
Default

Levodopa is the active ingredient.
Carbidopa is a buffer to help prevent nausea (too much Levodopa triggers the brain into thinking the stomach has nausea, but it is all in the brain).

Hence 25/100 is common Carbidopa/Levodopa ratio. You can find 10/100 C/L formulations, but more often people have nausea issues.

Cabidopa by itself is available as a separate medication. USA trade name is Lydosyn. Often as 25mg, taken in addition with 25/100 Sinemet

Comtan just helps the levodopa stick around longer. So if C/L starts to wear off after four hours, your doc may add Comtan to see if C/L benefits last six hours.
__________________
Born 1958. Diagnosed PD 2014.
Meds Sept 2016: 5x daily: 2 - Sinemet 25/100 + 200mg Comtan; 50/200 ER Sinement (bedtime).
Oct 2016 - DBS - bilateral GPi (PD & Dystonia). Still a work in progress. (Reduced meds to 4 - 25/100 & 50/200 ER Bedtime daily; but need six months to see how DBS/Meds play out)
TexasTom is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (06-22-2017)
Old 06-21-2017, 10:10 PM #10
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

I'd never heard of Lydosyn (i.e. a drug which contains only carbidopa).

So then, back to my own question from above: are there any other reasons why there isn't a drug which contains just levodopa and entacapone?

I guess one possible reason might be that there just isn't a big enough market for such a drug. Maybe you can just about do all you'd want to do, using a combination of Sinemet, Comtan and Lydosyn.
jeffreyn is offline   Reply With QuoteReply With Quote
Reply

Tags
carbidopa, ddc, entacapone, inhibitor, levodopa

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Pain-RX - Cox 2 Inhibitor caroline2 Vitamins, Nutrients, Herbs and Supplements 3 04-20-2019 09:45 PM
LRRK2 inhibitor may slow progression for all PWPs lab rat Parkinson's Disease 0 06-10-2014 07:23 PM
Ace inhibitor? Ccm47 Reflex Sympathetic Dystrophy (RSD and CRPS) 1 05-18-2013 09:23 AM
Common Herbs With MAO Inhibitor Activity imark3000 Parkinson's Disease 0 04-08-2011 01:45 AM
FP0011 can be a potent, safe glutamate release inhibitor ZucchiniFlower Parkinson's Disease 0 06-06-2007 05:03 PM


All times are GMT -5. The time now is 07:20 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.